Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Studyø.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
30 Aug 2022
Historique:
pubmed: 10 4 2022
medline: 2 9 2022
entrez: 9 4 2022
Statut: ppublish

Résumé

We aimed to investigate the association between protein intake and risk of inflammatory bowel disease [IBD] in the European Prospective Investigation into Cancer and Nutrition. A total of 413 593 participants from eight European countries were included. Dietary data were collected at baseline from validated food frequency questionnaires. Dietary data were calibrated to correct errors in measures related to each country-specific questionnaire. Associations between proteins [total, animal, and vegetable] or food sources of animal proteins, and IBD risk were estimated by Cox proportional hazard models. After a mean follow-up of 16 years, 177 patients with Crohn's disease [CD] and 418 with ulcerative colitis [UC], were identified. There was no association between total protein, animal protein, or vegetable protein intakes and CD or UC risks. Total meat and red meat intakes were associated with UC risk (hazard ratio [HR] for the 4th vs 1st quartile = 1.40, 95% confidence interval [CI] = 0.99-1.98, p-trend = 0.01; and 1.61, 95% CI = 1.10-2.36, p-trend = 0.007, respectively]. There was no association between other food sources of animal protein [processed meat, fish, shellfish, eggs, poultry] and UC. We found no association between food sources of animal proteins and CD risk. Meat and red meat consumptions are associated with higher risks of UC. These results support dietary counselling of low meat intake in people at high-risk of IBD.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
We aimed to investigate the association between protein intake and risk of inflammatory bowel disease [IBD] in the European Prospective Investigation into Cancer and Nutrition.
METHODS METHODS
A total of 413 593 participants from eight European countries were included. Dietary data were collected at baseline from validated food frequency questionnaires. Dietary data were calibrated to correct errors in measures related to each country-specific questionnaire. Associations between proteins [total, animal, and vegetable] or food sources of animal proteins, and IBD risk were estimated by Cox proportional hazard models.
RESULTS RESULTS
After a mean follow-up of 16 years, 177 patients with Crohn's disease [CD] and 418 with ulcerative colitis [UC], were identified. There was no association between total protein, animal protein, or vegetable protein intakes and CD or UC risks. Total meat and red meat intakes were associated with UC risk (hazard ratio [HR] for the 4th vs 1st quartile = 1.40, 95% confidence interval [CI] = 0.99-1.98, p-trend = 0.01; and 1.61, 95% CI = 1.10-2.36, p-trend = 0.007, respectively]. There was no association between other food sources of animal protein [processed meat, fish, shellfish, eggs, poultry] and UC. We found no association between food sources of animal proteins and CD risk.
CONCLUSIONS CONCLUSIONS
Meat and red meat consumptions are associated with higher risks of UC. These results support dietary counselling of low meat intake in people at high-risk of IBD.

Identifiants

pubmed: 35396592
pii: 6565743
doi: 10.1093/ecco-jcc/jjac054
pmc: PMC10020974
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1187-1196

Subventions

Organisme : International Agency for Research on Cancer
Organisme : European Commission
Organisme : Cancer Research UK
ID : C8221/A29017
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Am J Gastroenterol. 2010 Oct;105(10):2195-201
pubmed: 20461067
Gut. 2021 Jul;70(7):1287-1298
pubmed: 33811041
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
Inflamm Bowel Dis. 2016 Feb;22(2):345-54
pubmed: 26717318
Int J Epidemiol. 2015 Dec;44(6):1995-2005
pubmed: 26546032
Science. 2017 Oct 20;358(6361):359-365
pubmed: 29051379
Gastroenterology. 2019 Sep;157(3):647-659.e4
pubmed: 31014995
Gastroenterology. 2020 Sep;159(3):873-883.e1
pubmed: 32389666
Am J Clin Nutr. 2019 May 1;109(5):1472-1483
pubmed: 31051503
Gut. 2009 Dec;58(12):1606-11
pubmed: 19628674
Public Health Nutr. 2002 Dec;5(6B):1125-45
pubmed: 12639223
Gastroenterology. 2020 Mar;158(4):930-946.e1
pubmed: 31812509
Am J Epidemiol. 1986 Jul;124(1):17-27
pubmed: 3521261
Inflamm Bowel Dis. 2017 Jul;23(7):1088-1095
pubmed: 28604414
Gut. 2014 May;63(5):776-84
pubmed: 23828881
Front Immunol. 2016 Dec 07;7:554
pubmed: 28003811
Gastroenterology. 2010 Dec;139(6):1912-7
pubmed: 20950616
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Int J Epidemiol. 2008 Apr;37(2):368-78
pubmed: 18180242
Gastroenterology. 2017 Feb;152(2):313-321.e2
pubmed: 27793607
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
J Natl Cancer Inst. 2008 Dec 3;100(23):1658-9
pubmed: 19033567
J Crohns Colitis. 2018 Jan 24;12(2):129-136
pubmed: 29373726

Auteurs

Catherine Dong (C)

INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique-Hôpitaux de Paris and Université Paris-Saclay, Le Kremlin Bicêtre, France.

Simon S M Chan (SSM)

Norwich Medical School, Department of Medicine, University of East Anglia, Norwich, UK.
Department of Gastroenterology, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.

Prevost Jantchou (P)

INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
Sainte Justine University Hospital, Montréal, QC, Canada.

Antoine Racine (A)

INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique-Hôpitaux de Paris and Université Paris-Saclay, Le Kremlin Bicêtre, France.

Bas Oldenburg (B)

Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Alicia K Heath (AK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Cecilie Kyrø (C)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Bas Bueno de Mesquita (B)

National Institute for Public Health and the Environment [RIVM], Bilthoven, The Netherlands.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Verena A Katzke (VA)

Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Manuela M Bergman (MM)

Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition, Potsdam, Germany.

Domenico Palli (D)

Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute, Florence, Italy.

Giovanna Masala (G)

Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute, Florence, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale, Ragusa, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.

Sandra M Colorado-Yohar (SM)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
CIBER Epidemiologia y Salud Pública [CIBERESP], Madrid, Spain.
National School of Public Health, Research Group on Demography and Health, University of Antioquia, Medellín, Colombia.

Maria-Jose Sánchez (MJ)

CIBER Epidemiologia y Salud Pública [CIBERESP], Madrid, Spain.
Escuela Andaluza de Salud Pública [EASP], Granada, Spain.
Instituto de Investigación Biosanitaria, Granada, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Olof Grip (O)

Department of Gastroenterology and Hepatology, University Hospital Malmö, Malmö, Sweden.

Stefan Lindgren (S)

Department of Gastroenterology and Hepatology, University Hospital Malmö, Malmö, Sweden.

Robert Luben (R)

Strangeways Research Laboratory, Institute of Public Health, University of Cambridge, Cambridge, UK.

Inge Huybrechts (I)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Marc J Gunter (MJ)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Yahya Mahamat-Saleh (Y)

INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.

Marie-Christine Boutron-Ruault (MC)

INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.

Franck Carbonnel (F)

INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique-Hôpitaux de Paris and Université Paris-Saclay, Le Kremlin Bicêtre, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH